GlassScriptPhysician profile
Katlyn Amason
NPI 1144854498
$4,501.62
in general payments reported to CMS, 2019-2025
32 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what 87% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $519 · 2022: $379 · 2023: $680 · 2024: $1,778 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,714 · Travel and Lodging: $791 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,714.44 |
| Travel and Lodging | $790.63 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,146.37 | 2023-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $543.78 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $346.73 | 2024-2025 | Erleada, Akeega, Balversa |
| Smith+Nephew, INC. | $257.63 | 2022-2023 | Grafix Pl |
| Dendreon Pharmaceuticals LLC | $246.09 | 2024-2025 | Provenge |
| Astellas Pharma US INC | $237.35 | 2024 | Xtandi |
| Abbvie INC. | $235.56 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $207.82 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $151.46 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $137.10 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $125.99 | 2023-2025 | Trelstar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.98 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $82.69 | 2021-2025 | Keytruda, Lynparza |
| Glaxosmithkline, LLC. | $75.59 | 2021-2025 | Arexvy, Shingrix |
| Olympus America INC. | $65.02 | 2024-2025 | Itind System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $64.39 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $50.22 | 2024 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $49.59 | 2021 | |
| Coloplast Corp | $46.19 | 2023-2024 | Speedicath |
| Pfizer INC. | $39.50 | 2024-2025 | |
| Accord Healthcare, INC. | $37.56 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $36.48 | 2024 | |
| Calliditas Therapeutics US INC. | $30.92 | 2025 | Tarpeyo |
| Eisai INC. | $29.80 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.35 | 2022 | |
| Genzyme Corporation | $18.18 | 2021 | |
| Tolmar, INC. | $18.17 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.83 | 2025 | |
| Medtronic, INC. | $16.57 | 2025 | Interstim |
| Amgen INC. | $15.22 | 2024 | Prolia |
| Boston Scientific Corporation | $13.85 | 2025 | Wavewriter Alpha Prime 16 |
| Medline Industries LP | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katlyn Amason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.